证券之星消息，9月2日，史丹利（002588）融资买入1987.48万元，融资偿还1735.44万元，融资净买入 252.04万元，融资余额2.09亿元，近3个交易日已连续净买入累计786.85万元，近20个交易日中有11个交 易日出现融资净买入。 融资融券余额2.1亿元，较昨日上涨1.21%。 | 交易日 | 两融余额(元) | 余额变动(元) | 变动幅度 | | --- | --- | --- | --- | | 2025-09-02 | 2.10亿 | 251.47万 | 1.21% | | 2025-09-01 | 2.08亿 | 71.69万 | 0.35% | | 2025-08-29 | 2.07亿 | 465.54万 | 2.30% | | 2025-08-28 | 2.02亿 | -681.53万 | -3.26% | | 2025-08-27 | 2.09亿 | -242.70万 | -1.15% | | 交易日 | 融资净买入(元) | 融资余额(元) | 占流通市值比 | | --- | --- | --- | --- | | 2025-09-02 | 252.04万 | 2.09亿 ...

（编辑 王雪儿） 证券日报网讯 史丹利8月26日在互动平台回答投资者提问时表示，目前公司大股东股权质押情况整体风 险可控，公司与相关股东始终保持密切沟通，对质押状态进行严格监控。与此同时，公司也积极推动股 东拓宽融资渠道，探索多元化融资方式，减少对股权质押融资的依赖，进一步强化风险防控。公司也将 一如既往保持稳健经营，提升综合实力，为股东创造长期价值，保障公司和全体股东的利益。 ...

根据市场公开信息及8月25日披露的机构调研信息，知名私募睿璞投资近期对1家上市公司进行了调研， 相关名单如下： 1）史丹利 （广东睿璞投资参与公司电话会议） 调研纪要：公司上半年实现稳健增长，营业收入达63.91亿元，同比增长12.66%，归母净利润6.07亿 元，同比增长18.9%。复合肥销量200.41万吨，同比增长9.68%。二季度利润增长主要来自松滋新材料减 亏、无资产减值支出及磷化工出口放开后的盈利改善。复合肥毛利提升得益于产品结构优化、原料把控 增强及渠道与定价策略有效。公司未来3年核心增长点为复合肥市占率提升、磷化工板块延伸及氮钾资 源布局。 机构简介： 广东睿璞投资管理有限公司是国内研究能力强、激励制度领先的私募基金管理公司，成立于2015年8月 11日，注册资本1000万人民币，创始人为国内著名基金经理蔡海洪先生。与资本市场上众多的资产管理 者相比，我们团队的独特之处在于热爱投资、践行纯粹的价值投资、专注于能力圈、坚持独立判断、保 持勤奋和专业精神、坚守诚信尽责理念。我们以绝对收益为目标，追求稳健的复合收益率，致力于客户 财富的长期稳定增长。公司将坚持在"诚信规范"的前提下，以严格的管理、规 ...

Group 1: Galaxy Fund Research Insights - Galaxy Fund recently conducted research on six listed companies, focusing on their strategies to cope with market challenges and growth opportunities [1][2][3][4][5][6]. Group 2: Company-Specific Highlights - **Weixing New Materials (002372)**: The company is addressing industry demand pressure by enhancing product quality, accelerating business transformation, and implementing cost-saving measures. It has achieved channel penetration in Jiangsu, Zhejiang, and Shanghai, with plans for gradual expansion in other regions. The company anticipates a decline in product prices year-on-year in the first half of 2025, but a recovery in prices quarter-on-quarter is expected. The overall market demand remains weak, and the company aims for steady growth through new product combinations and a water ecosystem strategy [1]. - **Zhaoyi Innovation (603986)**: The company reported strong growth across its business lines in Q2 2024, with NOR Flash experiencing high single-digit growth and niche DRAM growing over 50%. The company expects significant revenue growth in niche DRAM in the second half of the year, driven by tight supply and rising contract prices. Overall gross margins are expected to remain stable, with a focus on customized storage technology and expanding into the automotive MCU market [2]. - **Tebao Bio**: The company is exploring combination therapies for hepatitis B treatment, focusing on optimizing drug strategies. It aims to enhance disease management through a comprehensive treatment network and is collaborating with Ligos for advanced solutions. New technologies like siRNA are entering clinical application stages, with a focus on optimizing combination therapy strategies [3]. - **Baili Tianheng**: The company is advancing its clinical trials for multiple cancer treatments in collaboration with BMS. It has submitted an IND application for its first nuclear medicine candidate and is progressing with several drug candidates in clinical trials. The company aims to become a leading player in oncology treatment within five years [4]. - **Stanley (002588)**: The company achieved steady growth in the first half of the year, with revenue reaching 6.391 billion yuan, a year-on-year increase of 12.66%. The compound fertilizer sales increased by 200,410 tons, up 9.68% year-on-year. Profit growth in Q2 was attributed to improved performance in new materials and better pricing strategies [5]. - **Reliable Co. (301009)**: The company experienced a decline in profits in Q2 due to promotional activities. It plans to expand its institutional and specialty channel business while launching its own brand. The company aims to increase its market share in baby care products despite facing intense competition [6].

Group 1: Zhaoyi Innovation - Zhaoyi Innovation reported good growth across all business lines in Q2 2024, with NOR Flash growing in the high single digits, niche DRAM up over 50%, MCU close to 20%, and sensor chips growing about 10% [1] - The company expects sequential growth in Q3, with significant revenue growth in niche DRAM and rising contract prices [1] - NOR Flash demand is increasing due to a rise in electronic product code volume, while supply remains tight due to wafer manufacturing capacity constraints [1] Group 2: Huijia Times - Huijia Times has optimized its product structure, achieving over 90% similarity to the product structure of a leading competitor [2] - The company has upgraded its shopping environment and service experience, resulting in increased daily sales, customer traffic, and average transaction value since the reopening of its Beijing Road store [2] - The supermarket segment is divided into boutique, lifestyle, and community supermarkets, with ongoing adjustments to enhance operations [2] Group 3: Baile Tianheng - Baile Tianheng is collaborating with BMS on new clinical trials for cancer treatments, with several drugs in various stages of clinical trials [3] - The company has submitted an IND application for its first nuclear medicine candidate and is advancing new toxin drugs into clinical trials [3] - R&D expenses reached 1.038 billion yuan by mid-year, with expectations for future clinical research costs to increase [3] Group 4: Stanley - Stanley achieved steady growth in H1, with revenue of 6.391 billion yuan, up 12.66% year-on-year, and net profit of 607 million yuan, up 18.9% [4] - The increase in profit was driven by reduced losses in new materials and improved profitability from phosphate chemical exports [4] - Future growth is expected from increased market share in compound fertilizers and expansion in the phosphate chemical sector [4] Group 5: Weiming Environmental - Weiming Environmental's environmental project operations generated revenue of 1.711 billion yuan, a year-on-year increase of 100 million yuan [5] - The equipment manufacturing segment saw a revenue decline of 300 million yuan, while new energy materials have yet to contribute to revenue [5] - The company is optimistic about future growth, with several projects expected to come online in the near term [5]

证券代码：002588 证券简称：史丹利 史丹利上市公司投资者关系活动记录表 编号：2025-004 上半年公司复合肥总销量 200.41 万吨，同比增长 9.68%，其中一季 度因东北春季肥集中发货增速较高，二季度销量略降但毛利稳定。公司 全年目标 360 万-370 万吨，达成路径是坚持"销量+利润"双考核，不盲 目降价冲量，聚焦高毛利产品，通过渠道下沉和终端价格管控保障增量。 5.复合肥在哪些区域增速较快？通过什么方式实现这些区域的销量 增长？ 投资者关系活动 类别 □特定对象调研 □分析师会议 □媒体采访 □业绩说明会 □新闻发布会 □路演活动 □现场参观 ☑ 电话会议 □其他：（请文字说明其他活动内容） 参与单位名称 及人员姓名 申万宏源证券 马昕晔 李绍程；上海原泽私募 王家晨；上海度势投资 顾宝成；鹏华基金 范晶伟；工银瑞信基金 易帆；上海宽远资产 舒启 航；长江证券 魏邈；交银施罗德基金 何雄；南方基金 王芝文；汇丰 晋信 姬静远；宝盈基金 侯星宇；银河基金 陈凯茜；富国基金 张啸伟； 泰康资管 王卓夫；人寿资产 赵文龙；太平基金 夏文奇；兴业资管 徐 莹莹；中信证券 孙臣兴；华安基金 王晨； ...

半年报密集披露，机构最新持仓动向曝光!二季度社保基金新进股共有41只。 社保基金新进股一览 | 证券代码 | 证券简称 | 社保基金家数 | 社保基金持股量（万股） | 占流通股比例（%） | 行业 | | --- | --- | --- | --- | --- | --- | | 688267 | 中触媒 | 1 | 320.00 | 3.45 | 基础化工 | | 300824 | 北鼎股份 | 1 | 1000.00 | 3.16 | 家用电器 | | 300416 | 苏试试验 | 3 | 1486.20 | 2.94 | 社会服务 | | 002588 | 史丹利 | 1 | 2199.99 | 2.56 | 基础化工 | | 301068 | 大地海洋 | 1 | 250.13 | 2.48 | 环保 | | 300850 | 新强联 | 2 | 555.56 | 2.08 | 电力设备 | | 300910 | 瑞丰新材 | 1 | 413.87 | 1.99 | 基础化工 | | 688513 | 苑东生物 | 1 | 276.14 | 1.56 | 医药生物 | | 688401 | 路维光 ...

Industry Focus - The 2025 CBP Bio-Agriculture Promotion Conference will focus on the core issues of biological transformation in the agricultural sector, aiming to interpret cutting-edge trends and development directions in bio-agriculture [1] - The Chinese fertilizer export situation for 2025 is expected to show "total volume growth year-on-year, continuous optimization of structure, and emerging markets" according to a senior consultant from Beijing Guotong Big Data Co., Ltd [1] - The Ministry of Agriculture and Rural Affairs has initiated a major pest and disease prevention campaign for autumn grain crops, organizing field observations in major producing provinces [1] Market Analysis - In Shandong and Chongqing, the agricultural input market is becoming more active as the autumn fertilizer preparation period begins, indicating a potential improvement in trading atmosphere [1] - The domestic monoammonium phosphate market is experiencing a significant divergence between strong upstream costs and weak downstream demand, leading to a stalemate in the market [1] Company Dynamics - Xingfa Group is actively responding to national supply and price stabilization calls amid a surge in agricultural input demand during the busy season [1] - Stanley's mid-year report shows a revenue of 6.391 billion yuan, a year-on-year increase of 12.66%, and a net profit of 607 million yuan, up 18.9% year-on-year [1] - Fubon Technology is leading a major agricultural microbiology project in Hubei Province focused on the creation and application demonstration of efficient crop nitrogen-fixing agents [1] - Jinzhe Group ranked 31st on the innovation list of the 2025 Shandong Top 100 Private Enterprises [1] - Hubei Yihua reported a net profit of 399 million yuan for the first half of 2025, a year-on-year decrease of 43.92% [1] Company Announcements - Salt Lake Co. announced the termination of a $300 million subscription intention for a merger with Highfield Resources Limited after a comprehensive evaluation [2] - Aojia Ecological reported a profit of 668,700 yuan for the first half of 2025, reversing a loss from the previous year, with a revenue of 101 million yuan, up 30.56% year-on-year [2]

Group 1 - The core viewpoint of the article highlights the recent movements of social security funds in the A-share market, revealing that they have entered the top ten circulating shareholders of 71 new stocks in the second quarter of 2025 [1] - Su Shi Testing has the highest number of new social security fund holdings, with 3 new holdings, while Shanghai Jahwa and Xin Qiang Lian each have 2 new holdings [1] - The article provides a detailed list of companies that have seen new social security fund investments, including their respective shareholding numbers, quantities, and market values [2][3][4][5] Group 2 - Specific companies mentioned include Su Shi Testing with 1,486.20 thousand shares valued at 213 million yuan, Shanghai Jahwa with 1,150.51 thousand shares valued at 242 million yuan, and Xin Qiang Lian with 555.56 thousand shares valued at 199 million yuan [2][3] - Other companies with new social security fund holdings include Hengdian East Magnetic, Nuofushin, and Baichu Electronics, each with 1 new holding, along with their respective share quantities and market values [2][3][4] - The article lists a total of 71 companies that have received new investments from social security funds, indicating a diverse range of industries from agriculture to electronics and pharmaceuticals [2][3][4][5]

Core Viewpoint - Stanley (002588) reported a strong performance in its 2025 mid-year financial results, with significant increases in revenue and net profit compared to the previous year [1] Financial Performance - Total revenue reached 6.391 billion yuan, a year-on-year increase of 12.66% [1] - Net profit attributable to shareholders was 607 million yuan, up 18.9% year-on-year [1] - In Q2, total revenue was 2.985 billion yuan, a decrease of 1.92% year-on-year, while net profit for the quarter was 319 million yuan, an increase of 17.19% [1] - Gross margin improved to 19.11%, up 2.81% year-on-year, and net margin increased to 9.46%, up 8.03% year-on-year [1] Cost and Efficiency - Total selling, administrative, and financial expenses amounted to 380 million yuan, accounting for 5.95% of revenue, a decrease of 9.27% year-on-year [1] - Earnings per share rose to 0.53 yuan, reflecting a 20.45% increase year-on-year [1] - The company's net asset per share increased to 6.21 yuan, up 10.72% year-on-year [1] Cash Flow and Debt - Operating cash flow per share was -0.09 yuan, a significant decrease of 186.9% year-on-year [1] - The company experienced a 126.7% increase in interest-bearing debt, rising to 1.891 billion yuan [1] - Cash and cash equivalents decreased by 27.88% to 1.338 billion yuan [1] Investment and Market Position - The company's return on invested capital (ROIC) was 9.6%, indicating average capital returns [3] - Historical data shows a median ROIC of 6.99% over the past decade, with the lowest recorded ROIC at 1.74% in 2019 [3] - Analysts expect the company's performance in 2025 to reach 1.01 billion yuan, with an average earnings per share forecast of 0.88 yuan [4] Fund Holdings - Notable funds holding Stanley shares include Guangfa Stable Growth Mixed A, which has newly entered the top ten holdings with 28.0076 million shares [5] - Other funds such as Xingquan Hengyi Bond A and Zhaoshang Growth Quantitative Stock A have increased their positions in Stanley [5]